PN

Potsangbam Naba Singh

Active Director Director DIN 10390646
DIN 10390646 First appointment Nov 2023 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Potsangbam Naba Singh

Data last updated:

Potsangbam Naba Singh is a Director at Multidisciplinary Translational Biotech Research Foundation (since 2023). The company operates in Non-Profit Organizations.

DIN 10390646
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 14 Nov 2023
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Nov 20232020Active

Board colleagues of Potsangbam Naba Singh

Directorship timeline

Open interactive timeline →
Multidisciplinary Translational Biotech Research Foundation
Premium access

Shareholding and investment profile for Potsangbam Naba Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Potsangbam Naba Singh

Potsangbam Naba Singh currently holds 1 directorship: Multidisciplinary Translational Biotech Research Foundation (Director, since 14 Nov 2023).

Potsangbam Naba Singh was first appointed on 14 Nov 2023 as Director at Multidisciplinary Translational Biotech Research Foundation.

The current boards of Potsangbam Naba Singh's companies include Deepak Singh Lourembam (Multidisciplinary Translational Biotech Research Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available